BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15643751)

  • 1. Oral mucosal lesions in a UK HIV/AIDS oral medicine clinic. a nine year, cross-sectional, prospective study.
    Zakrzewska JM; Atkin PA
    Oral Health Prev Dent; 2003; 1(1):73-9. PubMed ID: 15643751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years.
    Greenwood I; Zakrzewska JM; Robinson PG
    Oral Dis; 2002 Mar; 8(2):90-4. PubMed ID: 11991309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral manifestations of HIV infection in 600 South African patients.
    Arendorf TM; Bredekamp B; Cloete CA; Sauer G
    J Oral Pathol Med; 1998 Apr; 27(4):176-9. PubMed ID: 9563573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral manifestations of HIV infection by gender and transmission category in Mexico City.
    Ramirez-Amador V; Esquivel-Pedraza L; Sierra-Madero J; Ponce-de-Leon S; Ponce-de-Leon S
    J Oral Pathol Med; 1998 Mar; 27(3):135-40. PubMed ID: 9563806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and classification of HIV-associated oral lesions.
    Patton LL; Phelan JA; Ramos-Gomez FJ; Nittayananta W; Shiboski CH; Mbuguye TL
    Oral Dis; 2002; 8 Suppl 2():98-109. PubMed ID: 12164670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy.
    Patton LL; McKaig R; Strauss R; Rogers D; Eron JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Mar; 89(3):299-304. PubMed ID: 10710453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral manifestations of HIV/AIDS in clients attending TASO clinics in Uganda.
    Tirwomwe JF; Rwenyonyi CM; Muwazi LM; Besigye B; Mboli F
    Clin Oral Investig; 2007 Sep; 11(3):289-92. PubMed ID: 17476537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral HIV lesions and oral health behaviour of HIV-positive patients attending the Queen Elizabeth II Hospital, Maseru, Lesotho.
    Kamiru HN; Naidoo S
    SADJ; 2002 Dec; 57(11):479-82. PubMed ID: 12674869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral manifestations of HIV/AIDS in China: a review.
    Zhang X; Reichart PA; Song Y
    Oral Maxillofac Surg; 2009 Jun; 13(2):63-8. PubMed ID: 19404695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of the oral lesions of HIV infection in the developed world.
    Greenspan JS; Greenspan D
    Oral Dis; 2002; 8 Suppl 2():34-9. PubMed ID: 12164657
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral manifestations of HIV infection: a Panamerican perspective.
    Gillespie GM; Mariño R
    J Oral Pathol Med; 1993 Jan; 22(1):2-7. PubMed ID: 7678293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral manifestations of human immunodeficiency virus (HIV)-infected patients in Singapore.
    Lim AA; Leo YS; Lee CC; Robinson AN
    Ann Acad Med Singap; 2001 Nov; 30(6):600-6. PubMed ID: 11817287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral manifestations associated with human immunodeficiency virus infection in a Spanish population.
    Ceballos-Salobreña A; Aguirre-Urizar JM; Bagan-Sebastian JV
    J Oral Pathol Med; 1996 Nov; 25(10):523-6. PubMed ID: 8986962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral mucosal lesions and HIV viral load in the Women's Interagency HIV Study (WIHS).
    Greenspan D; Komaroff E; Redford M; Phelan JA; Navazesh M; Alves ME; Kamrath H; Mulligan R; Barr CE; Greenspan JS
    J Acquir Immune Defic Syndr; 2000 Sep; 25(1):44-50. PubMed ID: 11064503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics.
    Chidzonga MM
    Oral Dis; 2003 Nov; 9(6):317-22. PubMed ID: 14629334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of orodental findings in HIV-infected Romanian children.
    Flaitz C; Wullbrandt B; Sexton J; Bourdon T; Hicks J
    Pediatr Dent; 2001; 23(1):44-50. PubMed ID: 11242731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population.
    Bravo IM; Correnti M; Escalona L; Perrone M; Brito A; Tovar V; Rivera H
    Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E33-9. PubMed ID: 16388291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orofacial and systemic manifestations in 212 paediatric HIV patients from Chennai, South India.
    Ranganathan K; Geethalakshmi E; Krishna Mohan Rao U; Vidya KM; Kumarasamy N; Solomon S
    Int J Paediatr Dent; 2010 Jul; 20(4):276-82. PubMed ID: 20536589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of highly active antiretroviral therapy on frequency of oral warts.
    Greenspan D; Canchola AJ; MacPhail LA; Cheikh B; Greenspan JS
    Lancet; 2001 May; 357(9266):1411-2. PubMed ID: 11356441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.